The Use of Infusional 5-Fluorouracil, Mitomycin C, and Radiation as the Primary Management of Esophageal Cancer
The results of surgery or radiation therapy as primary management of esophageal cancer have been dismal, with median survivals generally less than 1 year and 5-year survivals under 10% (Earlan and Cunha-Melo 1980; Langer et al. 1986). There have been several reports which indicate that the use of concurrent chemotherapy and radiation therapy in the management of esophageal cancer may offer an alternative to the standard approaches (Coia et al. 1987; John et al. 1987; Keane et al. 1989). These studies demonstrate that excellent local control and palliation with a chance for long-term survival can be obtained.
KeywordsEsophageal Cancer Clin Oncol Esophageal Squamous Cell Carcinoma Squamous Cell Cancer Concurrent Chemotherapy
Unable to display preview. Download preview PDF.
- Coia L, Engstrom P, Paul A, Stafford P, Hanks G (1990) Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys (in press)Google Scholar